Preimplantation Genetic Diagnosis Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
Preimplantation Genetic Diagnosis
Over the forecast period, rising
rates of genetic diseases are anticipated to fuel market growth for
preimplantation genetic testing. For instance, the prevalence of live births
with Down's syndrome was 5.03 per 10,000 births between 2007 and 2016, according
to the study "Estimating Nationwide Prevalence of Live Births with Down
Syndrome and Their Medical Expenditures in Korea" published in Journal of
Korean Medical Science in August 2019.
Pre-implantation genetic testing
is a technique used to examine an embryo's genetic makeup before implantation.
The increasing prevalence of genetically unbalanced structures in infants and
young children makes it a significant procedure. This procedure examines an
embryo for a specific, known genetic disorder before implanting it. The main
drivers of the Preimplantation
Genetic Diagnosis Market growth are the rising number of fertility
clinics around the world, technological developments in genetic analysis, and
rising public-private investments in preimplantation genetic testing.
The most preferred method for
preimplantation genetic testing is anticipated to be genetic screening. Up
until 2032, the section is anticipated to generate close to 2/3 of the preimplantation
genetic testing market. The leading cause of disability and death in
the United States, according to the Centers for Disease Control and Prevention
(CDC), are chronic diseases like cancer, heart conditions, and diabetes.
Every year, the nation's
healthcare system spends close to US$ 3 billion on direct and indirect
expenses. Additionally, it is anticipated that in the upcoming years, market
growth will be aided by healthcare professionals' growing awareness of the
efficacy of genetic testing techniques.
Comments
Post a Comment